-
AI startup Onton raises $7.5M to reinvent the way the world discovers and decides what to buy - November 26, 2025
-
Forklift Market Positions for Recovery as Confidence Expected to Build from 2026 - November 26, 2025
-
PROCare achieves 300% order capacity increase and 99% picking accuracy with Forterro’s ERP solution, Orderwise - November 26, 2025
-
DHL boosts operational efficiency and customer communications with HappyRobot’s AI Agents - November 25, 2025
-
STENA LINE TEAMS UP WITH CAMERA TELEMATICS TO DRIVE SAFETY IMPROVEMENTS AT IRISH SEA PORTS - November 25, 2025
-
Stuut Technologies Raises $29.5 Million Series A Led by Andreessen Horowitz to Automate Accounts Receivable Work - November 20, 2025
-
INCREASED DIGITAL INVESTMENT REQUIRED TO KEEP PACE WITH 2026 CUSTOMS CHANGES - November 19, 2025
-
FULFILMENT SOLUTIONS FOR SPORTS MERCHANDISE: KEEPING OUR EYE ON THE GAME - November 19, 2025
-
COMPLEX, COSTLY & CONFUSING – THE END OF DE MINIMIS - November 19, 2025
-
Albatross raises $12.5 million to reinvent real-time product discovery for the modern web - November 18, 2025
86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months
Investment in digital agility to improve operational resilience is the area where most work is needed
86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives.
The survey, conducted by LogiPharma – the world’s leading annual conference covering pharmaceutical and medical device supply chains – asked global heads and directors of supply chain, logistics, procurement and IT how their organisations were upgrading their existing supply chain network to become more digitally agile.
Allowing logistics networks to be flexible and adapt to rapid changes and new innovations, including responding flexibly to geopolitical events and incorporating AI into networks were examples of how pharmaceutical and biotech companies say they will be enhancing their supply chains over the next year.
The number one challenge in building a digital supply chain was gaining visibility on the data and digital maturity roadmap, ensuring organisations can understand how digital transformation can help them recognise and plan for future challenges.
“One of the biggest focuses for our organisation has been utilising supply chain mapping solutions and embedding AI into that solution,” says Peter Stolba, Vice President, Business
Operations and Supply Chain, Trilink Biotechnologies.
“We have recently partnered with an external provider that has effectively mapped our tier one through to tier three suppliers. They have then overlaid AI to manage any risks that take place.
“Should any delays occur at a port, or airport, we are seeing real-time alerts and can respond sooner. Getting supplies has been incredibly difficult over the past two years and knowing immediately how to react to disruptions in the market has been essential.”
Learning from the pandemic
The global pandemic and geopolitical events such as the war in Ukraine have reinforced the need for operational resilience, particularly across global supply chains for vital products like pharmaceuticals.
Those surveyed said most work was needed in data management (22%), to improve the operational resilience, followed by temperature controls (21%) and investing in digital agility (18%).
61% felt that the most important factor for strengthening future supply chains was closer relationships with their suppliers to improve end-to-end visibility.
Peter Stolba adds:
“I think the pandemic has fueled the need for data visibility and the justification for investment into building a more robust digital supply chain. It is important that we leverage the information we have, and make key decisions based on our data points.”












